Skip to content
Research Article Open access CC BY 4.0

Quality Control Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications

Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir, Jinnat Ruksana Setu, Sonia Zaman, Yesmin Begum, Md. Shah Amran

Journal of Advances in Medical and Pharmaceutical Sciences · pp. 1–17 · Published 7 Jul 2017

10.9734/JAMPS/2017/33924

Abstract

The therapeutically performance of the pharmaceuticals must be constant and expectable.  In order to claim a pharmaceutical to be a quality drug, it must fulfill certain standards and specifications. The quality of pharmaceuticals is strongly related to the patient’s well-being. Quality control (QC) is an historical process in which proof is obtained that the appropriate level of quality has been achieved. QC can have no effect on the quality of the pharmaceuticals. It is merely a measuring process. QC must ensure that all the finished products contain active ingredients that comply with the qualitative and quantitative composition of the finished product described in the product registration dossier. The books containing the standards for drugs and other related substances are known as pharmacopeias. The pharmacopoeias contain a list of drugs and other related substances regarding their source, description, tests, formulas for preparing the same, action and uses, doses, storage conditions, etc. Ophthalmic pharmaceuticals are agents specially designed to be applied to the eyes. Among the drug products, ophthalmic pharmaceuticals are most important since eye is very sensitive and is easily irritated if the composition of the ophthalmic pharmaceutical is not suitable. The QC tests for ophthalmic pharmaceuticals are different in the different pharmacopoeias like IP, BP, and USP. Therefore the aim of this review was to mention QC tests for ophthalmic pharmaceuticals based on quality requirements of the different pharmacopoeias.

Quality control ophthalmic pharmaceuticals pharmacopoeia standard specification

Cited by 20

Gellan Gum Based Sol-to-Gel Transforming System of Natamycin Transfersomes Improves Topical Ocular Delivery

Karthik Yadav Janga, Akshaya Tatke, Narendar Dudhipala · The Journal of Pharmacology and Experimental Therapeutics · 2019

ASSESSMENT OF PHARMACEUTICAL QUALITY AND RELEASE KINETICS OF METOPROLOL TARTRATE EXTENDED RELEASE TABLETS AVAILABLE IN TURKISH DRUG MARKET

Ayşe GENÇER, Emrah AKGEYİK, Mustafa Sinan KAYNAK · Eskişehir Teknik Üniversitesi Bilim ve Teknoloji Dergisi - C Yaşam Bilimleri Ve Biyoteknoloji · 2020

Cannabidiol Loaded Topical Ophthalmic Nanoemulsion Lowers Intraocular Pressure in Normotensive Dutch-Belted Rabbits

Samir Senapati, Ahmed Adel Ali Youssef, Corinne Sweeney · Pharmaceutics · 2022

Thiolated hemicellulose containing mucoadhesive and permeation-enhancing ocular films of levodopa for potential treatment of myopia

Fazal Rahman Sajid Chughtai, Muhammad Hanif, Muhammad Azeem · International Journal of Biological Macromolecules · 2025

Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days

Judit Roura-Turet, Montserrat Rodriguez-Reyes, Laura Guerrero-Molina · American Journal of Health-System Pharmacy · 2021

Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation

Karthik Yadav Janga, Akshaya Tatke, Sai Prachetan Balguri · Artificial Cells, Nanomedicine, and Biotechnology · 2018

Analyzing ophthalmic suspension particle size distributions using laser diffraction: Placebo background subtraction method

Anh Vo, Xin Feng, William C. Smith · International Journal of Pharmaceutics · 2021

Mechanism of Ocular Penetration of Lipophilic Drugs from Lipophilic Vehicles

Carmen Liu, Jack Jonathan Maran, Ilva D. Rupenthal · Journal of Pharmaceutical Sciences · 2024

Nanocarriers for ocular drug delivery: current status and translational opportunity

Srividya Gorantla, Vamshi Krishna Rapalli, Tejashree Waghule · RSC Advances · 2020

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

20

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.